Samuel Valable
24
Documents
Identifiants chercheurs
- samuel-valable
- ResearcherId : B-7578-2008
- 0000-0003-0355-0270
- IdRef : 085766127
- ResearcherId : http://www.researcherid.com/rid/B-7578-2008
Présentation
samuel valable,hypoxia
Publications
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 24
- 24
- 20
- 19
- 16
- 16
- 6
- 5
- 4
- 4
- 4
- 4
- 3
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 2
- 1
- 2
- 10
- 5
- 4
- 2
|
Assessment of hypoxia and oxidative-related changes in a lung-derived brain metastasis model by [64Cu][Cu(ATSM)] PET and proteomic studiesEJNMMI Research, 2023, 13 (102), ⟨10.1186/s13550-023-01052-8⟩
Article dans une revue
hal-04308804v1
|
|
Nanosized zeolites as a gas delivery platform in a glioblastoma modelBiomaterials, 2020, 257, pp.120249. ⟨10.1016/j.biomaterials.2020.120249⟩
Article dans une revue
hal-02912573v1
|
|
Angiopoietin-2 Combined with Radiochemotherapy Impedes Glioblastoma Recurrence by Acting in an Autocrine and Paracrine Manner: A Preclinical StudyCancers, 2020, 12 (12), pp.3585. ⟨10.3390/cancers12123585⟩
Article dans une revue
hal-03082539v1
|
M2 macrophages are more resistant than M1 macrophages following radiation therapy in the context of glioblastomaOncotarget, 2017, 8 (42), pp.72597-72612. ⟨10.18632/oncotarget.19994⟩
Article dans une revue
hal-02100869v1
|
Hadrontherapy to target glioblastoma stem cells to overcome radioresistanceAssemblée générale du GDR Mi2B (Outils et méthodes nucléaires pour la lutte contre le cancer), Oct 2023, Bordeaux, France
Communication dans un congrès
hal-04262139v1
|
|
Impact of tumor reoxygenation by nanoparticles on tumors associated macrophages.24ème édition des journées de l'école doctorale EdNBISE, Mar 2019, Caen, France
Communication dans un congrès
hal-02266827v1
|